Friday, April 28, 2023
Description
The 2023 Cardio-Oncology Symposium addresses important clinical topics relevant to the cardiovascular health of patients with cancer. The symposium faculty will discuss new cancer treatments and strategies in diagnosis and management of cardiovascular disease in cancer patients from early diagnosis, treatment and long-term surveillance. It is anticipated that this CME activity will Improve care for cardio-oncology patients by understanding the short-term and delayed onset cardiotoxic effects of emerging cancer therapies. In addition, identifying when cardiovascular disease issues develop with cancer patient treatment strategies can be implemented more promptly. Case scenarios will be central to this educational activity.
For pricing information, see pricing tab below.
Dates and Times
Start: 4/28/2023 7:50 AM
End: 4/28/2023 4:15 PM
Objectives
At the conclusion of the continuing medical education activity participants should be able to:
1. Define the short-term and long-term cardiotoxic effects of contemporary cancer therapies.
2. Identify the best strategies to recognize when cardiovascular issues develop with your cancer patient.
3. Describe the role of cardioprotective therapy in your cancer patient population.
4. Compare cardiac imaging modalities to determine the optimal test for specific cancer patients.
5. Identify and integrate emerging cardio-oncology guidelines in clinical practice.
6. Recognize advancements and challenges in diagnosing and managing cardiac amyloidosis.
Agenda
Agenda
Moderators: Daniel Addison, MD and Bhuvaneswari Ramaswamy, MD, MRCP
Module 1
7:50 am Welcome and housekeeping remarks
Ayesha Hasan, MD and Raphael Pollock, MD, PhD
8:00 Managing Acute Coronary Syndromes in Cancer Patients
Dean Boudoulas, MD
8:15 Cardiac Ablation Therapy in Cancer Patients
Mahmoud Houmsse, MD
8:30 Cardiotoxicity after Cellular (CAR-T Cell) Therapies
Jonathan Brammer, MD
8:45 BTK inhibitor-induced Cardiac Arrhythmias
Adam Kittai, MD
9:00 New Directions of Genetics within Cardio-Oncology
Ray Hershberger, MD
9:15 Uses of STRAIN Imaging in Patients with Cancer
Adam Potter, MD
9:30 Addressing Cardiovascular Risk in Diverse Prostate Cancer Populations
Avirup Guha, MD, RPVI
9:45 Preventing and Managing Radiation associated CVD
Eric Miller, MD, PhD
10:00 Break
Module 2
10:10 Cardiovascular Toxicities of Immune Checkpoint Inhibitors
Ajay Vallakati, MBBS
10:25 Emerging Mechanisms of Tyrosine Kinase Inhibitor Cardiac Toxicity
Sakima Smith, MD, MPH
10:40 Managing Chronic CAD in the Cancer Patient
Richard Gumina, MD, PhD
10:55 Addressing Disparities in Cardio-Oncology Populations
Arnethea Sutton, PhD
11:10 Use of Advanced Cardiac Imaging in the Cancer Patient
Daniel Addison, MD
11:25 Managing Hypertension associated with Cancer Therapies
Jason Prosek, MD
11:40 Cardio-Oncology Needs from the Perspective of an Oncologist
Bhuvaneswari Ramaswamy, MD, MRCP
11:55 New Insights into the role of CHIP mutations and the Risk of Cardiovascular Disease
Uma Borate, MD, MS
Module 3
Breakout Sessions:
12:55 pm Welcome and housekeeping – Dr. Addison
Breakout A – Cardiac Complications of Cancer Immune Therapies – emerging role of Imaging
Paaladinesh Thavendiranathan, MD, Avirup Guha, MD, MPH, Alexa Meara, MD, and Ajay Vallakati, MBBS
1:00 Case Scenario (immune Checkpoint Myocarditis)
Timothy Gauntner, DO, PhD
1:05 Case Scenario (CAR-T cell induced heart failure)
1:10 Panel Discussion of Cases
Avirup Guha, MD, RPVI, Alexa Meara, MD, and Ajay Vallakati, MBBS.
1:30 Keynote Lecture: Immunotherapy-associated Cardiotoxicity -Where are We Going
Paaladinesh Thavendiranathan, MD
Breakout B – Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities
Daniel Addison, MD, Zachary Braunstein, MD, Mahmoud Houmsse, MD, and Jonathan Brammer, MD
2:00 Case Scenarios (BTKI associated Atrial Fibrillation)
2:05 Case Scenarios (Stem cell transplant associated heart failure)
2:10 Panel Discussion:
Daniel Addison, MD, Nausheen Akhter, MD, Mahmoud Houmsse, MD, and Jonathan Brammer, MD
2:30 Keynote Lecture: Novel Targeted Therapy associated cardiotoxicities- how do we screen and management these events?
Nausheen Akhter, MD
3:00 Break
Breakout C – Cardiac Amyloidosis in the 21st Century
Naresh Bumma, MD, Rami Kahwash, MD, Courtney Campbell, MD PhD, CV Fellow, MD
3:15 Case Scenarios (Indeterminate PYP Imaging, and course of care)
3:20 Case Scenarios (CHF in Myeloma, and Orthopedic associations) -
3:25 Panel Discussion:
Naresh Bumma, MD, Rami Kahwash, MD, Courtney Campbell, MD, PhD
3:45 Keynote: New Directions in Cardiac Amyloidosis Treatment
4:15 Meeting Adjournment
Daniel Addison, MD
Pricing
| Tier | Price |
|---|---|
| Physician, attending in person | $0.00 |
| Nurse/Nurse Practitioner, attending in person | $0.00 |
| Allied Medical Professional, attending in person | $0.00 |
| Other, attending in person | $0.00 |
| Physician. participating online | $0.00 |
| Nurse/Nurse Practitioner, participating online | $0.00 |
| Allied Health Professional, participating online | $0.00 |
| Other, participating online | $0.00 |
Location
The Ohio State University Medical Center
Biological Research Tower
460 W. 12th Avenue
Columbus, OH 43210
Accreditation
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.